Yasuharu Aki

618 total citations
35 papers, 506 citations indexed

About

Yasuharu Aki is a scholar working on Physiology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Yasuharu Aki has authored 35 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Physiology, 12 papers in Cardiology and Cardiovascular Medicine and 10 papers in Molecular Biology. Recurrent topics in Yasuharu Aki's work include Nitric Oxide and Endothelin Effects (17 papers), Eicosanoids and Hypertension Pharmacology (7 papers) and Electrolyte and hormonal disorders (7 papers). Yasuharu Aki is often cited by papers focused on Nitric Oxide and Endothelin Effects (17 papers), Eicosanoids and Hypertension Pharmacology (7 papers) and Electrolyte and hormonal disorders (7 papers). Yasuharu Aki collaborates with scholars based in Japan and Nigeria. Yasuharu Aki's co-authors include Youichi Abe, Shoji Kimura, Toshiaki Tamaki, Akira Nishiyama, Hideyasu Kiyomoto, Hiroshi Iwao, Hong He, Akira Miyatake, Yoshihide Fujisawa and Masakazu Kohno and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Kidney International and Hypertension.

In The Last Decade

Yasuharu Aki

35 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasuharu Aki Japan 14 148 141 139 98 82 35 506
M. R. Lee United Kingdom 10 145 1.0× 184 1.3× 97 0.7× 199 2.0× 112 1.4× 19 599
Miklos Gellai United States 18 329 2.2× 170 1.2× 345 2.5× 111 1.1× 66 0.8× 29 754
J G Gerber United States 14 237 1.6× 153 1.1× 163 1.2× 108 1.1× 35 0.4× 22 663
J. C. Pelayo United States 14 178 1.2× 241 1.7× 179 1.3× 128 1.3× 168 2.0× 19 788
R. A. Ferrone United States 12 188 1.3× 140 1.0× 94 0.7× 59 0.6× 35 0.4× 13 498
G. F. DiBona United States 9 257 1.7× 85 0.6× 73 0.5× 75 0.8× 62 0.8× 10 470
Jia L. Zhu United States 8 242 1.6× 107 0.8× 224 1.6× 36 0.4× 39 0.5× 12 435
Louis Wj Australia 14 150 1.0× 133 0.9× 76 0.5× 57 0.6× 41 0.5× 29 547
Tatiana A. Assaykeen United States 11 236 1.6× 138 1.0× 86 0.6× 71 0.7× 56 0.7× 17 483
Alexandra M. Hopwood United Kingdom 10 105 0.7× 130 0.9× 164 1.2× 43 0.4× 101 1.2× 13 435

Countries citing papers authored by Yasuharu Aki

Since Specialization
Citations

This map shows the geographic impact of Yasuharu Aki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuharu Aki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuharu Aki more than expected).

Fields of papers citing papers by Yasuharu Aki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuharu Aki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuharu Aki. The network helps show where Yasuharu Aki may publish in the future.

Co-authorship network of co-authors of Yasuharu Aki

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuharu Aki. A scholar is included among the top collaborators of Yasuharu Aki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuharu Aki. Yasuharu Aki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takahashi, Norihiro, Hideyasu Kiyomoto, Yasuharu Aki, et al.. (2004). Reduction of Oxidized Low-Density Lipoprotein by the Long-Term Use of Vitamin E-Coated Dialyzers in Hemodialysis Patients. Dialysis & Transplantation. 33(4). 197–207. 5 indexed citations
2.
Kiyomoto, Hideyasu, Naoki Kondo, Kumiko Moriwaki, et al.. (2004). Nephrotic syndrome caused by focal segmental glomeruloscrelosis with dentaterubral-pallidoluysian atrophy.. Nihon Naika Gakkai Zasshi. 93(10). 2201–2203. 1 indexed citations
3.
Matsubara, Keisuke, Hideyasu Kiyomoto, Kumiko Moriwaki, et al.. (2004). Leptin kinetics during peritoneal dialysis in acutely uraemic rats. Nephrology. 9(5). 256–261. 3 indexed citations
4.
Ishii, Kaori, Matlubur Rahman, Yasuharu Aki, et al.. (2004). Blood flow-dependent changes in intrarenal nitric oxide levels during anesthesia with halothane or sevoflurane. European Journal of Pharmacology. 498(1-3). 267–273. 9 indexed citations
5.
Takahashi, Norihiro, Hideyasu Kiyomoto, Koji Ohmori, et al.. (2002). A New Method for Evaluation of Split Renal Cortical Blood Flow with Contrast Echography. Hypertension Research. 25(1). 77–83. 37 indexed citations
6.
Hitomi, Hirofumi, Hideyasu Kiyomoto, Yasuharu Aki, et al.. (2000). A new approach for glomerular lesions: evaluation of scanning acoustic microscopy (SAM) for experimental glomerular disease in rats. Ultrasound in Medicine & Biology. 26(4). 571–577. 4 indexed citations
7.
Nishiyama, Akira, Akira Miyatake, Yue Wang, et al.. (1999). Effects of halothane on renal hemodynamics and interstitial nitric oxide in rabbits. European Journal of Pharmacology. 367(2-3). 299–306. 13 indexed citations
9.
Aki, Yasuharu, et al.. (1997). The Role of Basally Synthesized Nitric Oxide in Modulating the Renal Vasoconstrictor Action of Angiotensin II.. Hypertension Research. 20(4). 251–256. 7 indexed citations
10.
Tamaki, Toshiaki, Hong He, Akira Nishiyama, et al.. (1996). Vasodilation induced by vasopressin V2 receptor stimulation in afferent arterioles. Kidney International. 49(3). 722–729. 52 indexed citations
11.
He, Hong, et al.. (1996). Lack of vasodilatory response in skeletal muscle blood vessels of aged spontaneously hypertensive rats. Heart and Vessels. 11(1). 1–9. 2 indexed citations
12.
He, Hong, Yoshihide Fujisawa, Tomoyuki Kita, et al.. (1995). Effects of a synthetic rat adrenomedullin on regional hemodynamics in rats. European Journal of Pharmacology. 273(3). 209–214. 76 indexed citations
13.
He, Hongbin, et al.. (1994). Effects of CV-11974 on renal haemodynamics and renal function in dogs.. PubMed. 5. 79–83. 1 indexed citations
14.
Yoshida, Hiroyuki, et al.. (1994). Effects of Angiotensin II on Isolated Rabbit Afferent Arterioles. The Japanese Journal of Pharmacology. 66(4). 457–464. 12 indexed citations
15.
Aki, Yasuharu, Toshiaki Tamaki, Hideyasu Kiyomoto, et al.. (1994). Nitric Oxide May Participate in V2 Vasopressin-Receptor-Mediated Renal Vasodilation. Journal of Cardiovascular Pharmacology. 23(2). 331–336. 44 indexed citations
16.
Kiyomoto, Hideyasu, Hirohíde Matsuo, Toshiaki Tamaki, et al.. (1992). Effect of L-NG-Nitro-Arginine, Inhibitor of Nitric Oxide Synthesis, on Autoregulation of Renal Blood Flow in Dogs.. The Japanese Journal of Pharmacology. 58(2). 147–155. 22 indexed citations
17.
Shoji, Tetsuo, Yasuharu Aki, Toshiaki Tamaki, et al.. (1992). Regional Hemodynamic Effects of Betaxolol, a New Selective .BETA.1-Blocker, and Atenolol in Conscious Spontaneously Hypertensive Rats.. The Japanese Journal of Pharmacology. 60(3). 253–259. 2 indexed citations
18.
Nishiyama, Akira, Toshiaki Tamaki, Hong He, et al.. (1992). Effects of semotiadil fumarate (SD-3211) on renal hemodynamics and function in dogs. European Journal of Pharmacology. 218(2-3). 311–317. 8 indexed citations
19.
Tamaki, Toshiaki, Tetsuo Shoji, Yasuharu Aki, et al.. (1991). Forskolin preferentially dilates the afferent arteriole in the canine kidney.. The Japanese Journal of Pharmacology. 55(1). 161–164. 7 indexed citations
20.
Aki, Yasuharu, et al.. (1990). Intrarenal Vascular Sites of Action of Adenosine and Glucagon. The Japanese Journal of Pharmacology. 54(4). 433–440. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026